ESR1 and breast carcinoma: AKR1B10 behaves as a metastasis enhancer in breast cancer via its ability to promote fatty acid oxidation, although high expression was only associated with poor distant metastasis free survival in ER- and HER2 + breast cancer, not in ER + breast cancer [47].